The North Denmark Region and Biopeople, in collaboration with partners in the Baltic Sea region, have proposed “HealthShare,” a project designed to reduce hospital-acquired infections and drug-resistant bacteria.
The program calls for linking clinical test sites with regional innovation and support to reduce the current infection level by developing, producing and applying new diagnostic tools and services and making better use of existing research and innovation infrastructure.
Antimicrobial resistance is increasingly becoming a serious global public health threat. It hinders the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. Infections caused by drug-resistant bacteria can lead to patient complications, extended hospital stays and even death.
HealthShare may help overcome obstacles to introducing new approaches and help to facilitate cooperation between hospital clinics and companies. A lack of collaboration is one of the main reasons it takes so long to bring new diagnostic tools and faster, more effective services to the market.